Invention Grant
- Patent Title: Processes for generating TIL products enriched for tumor antigen-specific T-cells
-
Application No.: US17736953Application Date: 2022-05-04
-
Publication No.: US11713446B2Publication Date: 2023-08-01
- Inventor: Cecile Chartier-Courtaud , Krit Ritthipichai
- Applicant: Iovance Biotherapeutics, Inc.
- Applicant Address: US CA San Carlos
- Assignee: IOVANCE BIOTHERAPEUTICS, INC.
- Current Assignee: IOVANCE BIOTHERAPEUTICS, INC.
- Current Assignee Address: US CA San Carlos
- Agency: Morgan, Lewis & Bockius LLP
- Main IPC: C12N5/0783
- IPC: C12N5/0783 ; A61K35/17
Abstract:
The present invention provides improved and/or shortened processes and methods for reprogramming TILs in order to prepare therapeutic populations of TILs with increased therapeutic efficacy. Such reprogrammed TILs find use in therapeutic treatment regimens.
Public/Granted literature
- US20230060123A9 PROCESSES FOR GENERATING TIL PRODUCTS ENRICHED FOR TUMOR ANTIGEN-SPECIFIC T-CELLS Public/Granted day:2023-02-23
Information query
